Home/Filings/4/0001209191-22-019341
4//SEC Filing

LEBEL FRANCOIS 4

Accession 0001209191-22-019341

CIK 0000831547other

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 7:11 PM ET

Size

7.3 KB

Accession

0001209191-22-019341

Insider Transaction Report

Form 4
Period: 2022-03-15
LEBEL FRANCOIS
Chief Medical Officer
Transactions
  • Sale

    Common Stock, $0.001 par value

    2022-03-15$0.70/sh25,130$17,717280,190 total
  • Sale

    Common Stock, $0.001 par value

    2022-03-16$0.71/sh25,105$17,724255,085 total
Holdings
  • Common Stock, $0.001 par value

    (indirect: By 401(k))
    7,226
Footnotes (1)
  • [F1]All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.

Issuer

SPECTRUM PHARMACEUTICALS INC

CIK 0000831547

Entity typeother

Related Parties

1
  • filerCIK 0001038704

Filing Metadata

Form type
4
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 7:11 PM ET
Size
7.3 KB